Research on the efficacy of prophylactic use of Acidosalus® probiotic in women with recurrent cystitis;Ispitivanje djelotvornosti profilaktičke primjene probiotika Acidosalus® u žena s rekurentnim cistitisom

Infektoloski Glasnik

Volumn 30, Issue 1, 2010, Pages 21-25

  Škerk, Višnja ^a   Ferinčević, Rosa ^b   Markotić, Alemka ^a   Andrašević, Saša ^a   Milošević, Velimir ^a   Vargović, Martina ^a   Pasini, Miram ^a   Turčić, Petra ^c   Begovac, Josip ^a  

^a Croatia   (Croatia)

^b BOBLab doo   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Lactobacillus; Probiotics; Recurrent urinary tract infections

Indexed keywords

ACIDOSALUS; ANTIBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; CYSTITIS; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PROPHYLAXIS; RECURRENT CYSTITIS; TREATMENT DURATION;

EID: 78049350497     PISSN: 13312820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sobel JD, Kaye D., ur. Urinary tract infection. U: Mandell GL, Bennet JE, Dolin R. Mandell, Douglas, and Bennett's Principles & Practice of Infectious Diseases. New York: Elsevier/Churchill Livingstone, 2010:957-85.
2. Škerk V, Škerk V, Jakšić J i sur. Research of urinary tract infections in family medicine physicians' offices-empiric antimicrobial therapy of urinary tract infections-Croatian experience. Coll Antropol 2009;33:625-31.
3. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001;17:259-68.
4. Škerk V, Tambić-Andrašević A, Andrašević S i sur. ISKRA smjernice antimikrobnog liječenja i profilakse infekcija mokračnog sustava - hrvatske nacionalne smjernice. Liječ Vjesn 2009;131:105-18.
5. Macfarlane GT, Cummings JH. Probiotics, infection and immunity. Curr Opin Infect Dis 2002;15:501-6.
6. De Simone C, Vesely R, Bianchi SB, Jirillo E. The role of probiotics in modulation of the immune system in man and in animals. Int J Immunother 1993;9:23-8.
7. Vujić G. Peroralni probiotici u liječenju infekcija donjeg genitalnog trakta: dvostruko slijepi klinički pokus/preliminarna analiza. 1. hrvatski kongres o urogenitalnim i spolnoprenosivim infekcijama. Opatija; 2009, str. 34-5, No. 23.
8. Uputa o medicinskom proizvodu Acidosalus®.
9. Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 1990;3:335-44.
10. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001;73:437S-43.
11. Mai V, Morris JG Jr. Colonic bacterial flora: changing understandings in the molecular age. J Nutr 2004;134:459-64. (Pubitemid 38141833)
12. Kalenić S. Normalna flora čovjeka. U: Kalenić S, Mlinarić-Missoni E i sur. Medicinska bakteriologija i mikologija. Zagreb: Merkur A.B.D., 2001, str. 393-9.
13. Tomić Karović Kruna. Lactobacillus acidophilus i acidofilno mlijeko. Disertacija. Zagreb: Medicinski fakultet Sveučilišta u Zagrebu; 1966, 233 str.
14. Brlečić M, Škerk V, Milošević V i sur. Iskustva u primjeni pripravka Acidosalus® - fermentiranog mliječnog probiotika s Lactobacillus acidophilus. 8. simpozij o spolno prenosivim bolestima i urogenitalnim infekcijama. Opatija; 2006, str.16, No 9.
15. Škerk V, Tambić-Andrašević A, Ferinčević R i sur. Djelotvornost profilaktičke vaginalne primjene acidosalusa u žena s rekurentnim cistitisom. 9. simpozij o spolno prenosivim bolestima i urogenitalnim infekcijama. Opatija; 2007, str.11, No 6.
16. Škerk V, Tambić-Andrašević A, Ferinčević R i sur. Ispitivanje djelotvornosti i podnošljivosti vaginalne primjene probiotika Lactobacillus acidophilus u žena sa simptomima kolpitisa. Infektol Glasn 2007;27:81-5.
17. Isenberg HD, Berkman JI, Carito SL. Factors leading to overt monilial disease II: retardation of growth of Candida albicans by methabolic and products of intestinal bacteria. Antimicrob Agents Ann 1960;10:570-5.
18. Will TE. Lactobacillus overgrowth for treatment of moniliary vulvovaginitis. Lancet 1979;2:482.
19. Sandler B. Lactobacillus for vulvovaginitis. Lancet 1979;2:791-2.
20. Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992;116:353-7.
21. Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989;27:2328-30. (Pubitemid 19240622)
22. Mastromarino P, Macchia S, Meggiorini L i sur. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect 2009;15:67-74.
23. Klebanoff SJ, Coombs RW. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 1991;174:289-92.
24. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol 2006;24:28-32. (Pubitemid 43298680)